Endocrinology Diabetology and Metabolic Diseases, CHU Clermont-Ferrand, University Hospital of Clermont-Ferrand, F-63000 Clermont-Ferrand, France.
Institut Génétique, Reproduction & Développement (iGReD), CNRS, INSERM, University of Clermont Auvergne, F-63000 Clermont-Ferrand, France.
Int J Environ Res Public Health. 2022 Mar 18;19(6):3606. doi: 10.3390/ijerph19063606.
Objective: Cardiovascular effects of thyroid hormones may be measured through heart rate variability (HRV). We sought to determine the impact of hyperthyroidism on HRV. Design: A systematic review and meta-analysis on the impact of hyperthyroidism on HRV. Methods: PubMed, Cochrane, Embase and Google Scholar were searched until 20 August 2021 for articles reporting HRV parameters in untreated hyperthyroidism and healthy controls. Random-effects meta-analysis was stratified by degree of hyperthyroidism for each HRV parameter: RR intervals (or Normal-to-Normal intervals—NN), SDNN (standard deviation of RR intervals), RMSSD (square root of the mean difference of successive RR intervals), pNN50 (percentage of RR intervals with >50 ms of variation), total power (TP), LFnu (low-frequency normalized unit) and HFnu (high-frequency), VLF (very low-frequency), and LF/HF ratio. Results: We included 22 studies with 10,811 patients: 1002 with hyperthyroidism and 9809 healthy controls. There was a decrease in RR (effect size = −4.63, 95% CI −5.7 to −3.56), SDNN (−6.07, −7.42 to −4.71), RMSSD (−1.52, −2.18 to −0.87), pNN50 (−1.36, −1.83 to −0.88), TP (−2.05, −2.87 to −1.24), HFnu (−3.51, −4.76 to −2.26), and VLF power (−2.65, −3.74 to −1.55), and an increase in LFnu (2.66, 1.55 to 3.78) and LF/HF ratio (1.75, 1.02 to 2.48) (p < 0.01). Most parameters had ES that was twice as high in overt compared to subclinical hyperthyroidism. Increased peripheral thyroid hormones and decreased TSH levels were associated with lower RR intervals. Conclusions: Hyperthyroidism is associated with a decreased HRV, which may be explained by the deleterious effect of thyroid hormones and TSH. The increased sympathetic and decreased parasympathetic activity may have clinical implications.
甲状腺激素对心血管的影响可通过心率变异性(HRV)来衡量。我们旨在确定甲状腺功能亢进症对 HRV 的影响。
一项关于甲状腺功能亢进症对 HRV 影响的系统评价和荟萃分析。
检索 PubMed、Cochrane、Embase 和 Google Scholar,以获取截至 2021 年 8 月 20 日报告未经治疗的甲状腺功能亢进症和健康对照者 HRV 参数的文章。随机效应荟萃分析根据每个 HRV 参数的甲状腺功能亢进症程度进行分层:RR 间期(或正常-正常间期-NN)、SDNN(RR 间期标准差)、RMSSD(连续 RR 间期均方根差)、pNN50(RR 间期变化超过 50ms 的百分比)、总功率(TP)、LFnu(低频标准化单位)和 HFnu(高频)、VLF(极低频)和 LF/HF 比值。
我们纳入了 22 项研究,共 10811 例患者:1002 例甲状腺功能亢进症患者和 9809 例健康对照者。RR 间期(效应大小=-4.63,95%CI-5.7 至-3.56)、SDNN(-6.07,-7.42 至-4.71)、RMSSD(-1.52,-2.18 至-0.87)、pNN50(-1.36,-1.83 至-0.88)、TP(-2.05,-2.87 至-1.24)、HFnu(-3.51,-4.76 至-2.26)和 VLF 功率(-2.65,-3.74 至-1.55)降低,而 LFnu(2.66,1.55 至 3.78)和 LF/HF 比值(1.75,1.02 至 2.48)升高(p<0.01)。与亚临床甲状腺功能亢进症相比,显性甲状腺功能亢进症的大多数参数的 ES 高 2 倍。外周甲状腺激素升高和 TSH 水平降低与 RR 间期缩短有关。
甲状腺功能亢进症与 HRV 降低有关,这可能是甲状腺激素和 TSH 的有害作用所致。交感神经活性增加和副交感神经活性降低可能具有临床意义。